Main menu

People in the News

Fred Hirsch

Biocept said that Fred Hirsch has joined its clinical advisory board. Hirsch is a professor of medicine and pathology at the University of Colorado Cancer Center.

Oct 11, 2017

Tom Civik

Tom Civik has been appointed as chief commercial officer of Foundation Medicine and will start his new position in mid November. Most recently, he was a vice president and franchise leader at Genentech, where he was responsible for several oncology products. Earlier, he held various commercial positions at Sanofi-Synthelabo. Civik holds a BA from St. Norbert College and a master's degree in business administration from the Kellogg School of Management at Northwestern University.

Oct 10, 2017

John Kenny

John Kenny has been appointed CEO of Meridian Bioscience, effective Oct. 9. He replaces John Kraeutler who is stepping down to become executive chairman. Kraeutler announced in May his plans to resign from the company as CEO. Kenny also was appointed to Meridian's board, effective Oct. 9. Kenny was most recently senior vice president, general manager, North America at Siemens Healthcare. He has also held executive level roles at Becton Dickinson, Leica Biosystems, and Quest Diagnostics.

Oct 03, 2017

Alan Copperman

Alan Copperman has joined health information firm Sema4 as its chief medical officer. Copperman is director of the division of reproductive endocrinology and infertility, and vice chairman of the department of obstetrics, gynecology, and reproductive science at the Icahn School of Medicine at Mount Sinai. He also is managing partner at Reproductive Medicine Associates of New York.

Oct 03, 2017

Jeffrey Rona

Jeffrey Rona has resigned from his position as CFO of Great Basin Scientific, effective October 6, 2017.

Oct 03, 2017

Paul Eros

Novacyt has appointed Paul Eros as commercial director, effective Nov. 1. Eros joins Novacyt from DiaSorin, where he was VP of molecular marketing for more than five years. He has also worked for Becton Dickinson and Roche Diagnostics

Oct 03, 2017

Jeffery Luber

Atlas Genetics announced today that Jeffrey Luber has been appointed CEO and John Clarkson, current founding CEO, will become Executive Chairman. Mr. Luber joins the board with experience in the life sciences industry, including roles in both public and private companies. Most recently, he led the return to growth and sale of Good Start Genetics to Invitae. Prior to this, Luber was CEO of Exact Sciences, where he executed its turnaround and strategic transaction with Genzyme.

Oct 02, 2017

Doug Fisher, Jeffrey Cossman

Precipio has elected Doug Fisher and Jeffrey Cossman to its board in order to fill existing vacancies. Fisher will serve on Precipio's audit committee and compensation committee. Cossman will serve on the company's compensation committee and will chair the nominating and corporate governance committee.

Fisher is currently executive-in-resident at venture capital firm InterWest Partners, where he has worked since March 2009. He is also chief business officer at Sera Prognostics. Cossman is founder of the United States Diagnostic Standards, where he also served as CEO and chairman. Prior to that, he was CSO and a member of the board of The Critical Path Institute and as medical director of Gene Logic.

Sep 29, 2017

Michael Epplen

Michael Epplen has been promoted to president of Sunquest Information Systems. Epplen had been serving as chief operating officer of Sunquest as well as president of Atlas Medical, which Sunquest parent company Roper Technologies acquired two years ago. He previously spent five years as CEO of Data Innovations, another company that Roper bought in 2015.

Sep 29, 2017

Timothy Ring and David Melcher

Becton Dickenson announced today that Timothy Ring and David Melcher have joined its board of directors. Ring has served as chairman and CEO of Bard since August 2003. He previously joined Bard in 1992 and has served as VP of human resources, group VP of Bard International, and in additional roles. Ring is also a director of Quest Diagnostics, a trustee for the New Jersey Health Foundation, and a board member for the Advanced Medical Technology Association. Melcher has been president and CEO of the Aerospace Industries Association since 2015. Prior to AIA, Melcher was president and CEO of Exelis, a spinoff of ITT Corporation. In addition to being a director for Bard, Melcher is also a member of the Federal Aviation Administration's NextGen Advisory Committe, providing advice on policy-level issues for US aviation modernization.

Sep 27, 2017

Greg Richard

Interpace Diagnostics has promoted Greg Richard to the position of chief commercial officer. He previously served as senior vice president of commercial operations. Richard has worked in the healthcare business in various positions for more than 25 years, starting in sales at Aetna, and then moving to Genentech as the director of managed care. He also served as vice president of managed care for Quest Diagnostics, vice president of sales for the Northeast division of LabCorp, and worked for several privately held companies focused in various areas including specialty CROs, molecular diagnostics, and anatomic pathology services.

Sep 27, 2017

Eric Brouwer

SQI Diagnostics announced Eric Brouwer has joined the firm as chief scientific officer. He will be responsible for executing SQI's R&D program. Brouwer was most recently CSO of Trinity Biotech and CEO of Trinity's Swedish subsidiary Fiomi Diagnostics. Before that he spent 15 years at Abbott Laboratories.

Sep 20, 2017

Micah Litow

Micah Litow has joined cancer screening test firm Preora Diagnostics as its chief marketing and business development officer. He previously was at IA Collaborative where he led the healthcare practice. Before that, he was director of innovation at Leica Biosystems.

Sep 20, 2017

Patrick Young

True Health named Patrick Young to its board of directors. Young is president of Population Health for Hackensack Meridian Health. True Health provides biomarker testing cardiovascular diseases, diabetes, autoimmune disorders, metabolic conditions, and other ailments. It began offering its hereditary cancer test called genTrue earlier this year.

Sep 19, 2017

Michael Korn

Michael Korn has been appointed the chief medical officer of Caris Life Sciences, where he will guide the firm's research efforts and clinical strategies for the Adapt Biotargeting System and Caris Molecular Intelligence tumor profiling. Korn is a professor of medicine in the division of hematology/concology at the University of California, San Francisco, and he replaces John Marshal, who was CMO for Caris on a part-time basis. Marshall will continue as chairman of the Precision Oncology Alliance, which is powered by Caris.

Sep 15, 2017

Philipp Manser, Karl Erik Clausen

Unilabs CFO Philipp Manser has resigned from the firm for personal reasons, the company said. Its previous CFO Karl Erik Clausen, who had retired, is rejoining Unilabs as interim CFO while the company searches for a permanent successor.

Sep 13, 2017

Felice Schnoll-Sussman

Felice Schnoll-Sussman has been elected a director at Interpace Diagnostics, where she will serve on the firm's audit committee. She will be a Class II director and her term expires in 2018. Schnoll-Sussman is an associate professor of clinical medicine at Weill Cornell Medical College, where she is the director of the Jay Monahan Center for Gastrointestinal Health. She also is associate attending physician in gastroenterology at New York Presbyterian Hospital.

Sep 12, 2017

James Wisecarver

James Wisecarver has been installed as the 2017-2018 president of the American Society for Clinical Pathology. He is currently vice chair for clinical affairs and medical director of the University of Nebraska Medi al Center Clinical Laboratories. He also is the director of the Human DNA Identification Laboratory at UNMC.

Sep 12, 2017

Gerald Krueger

DermTech has appointed Gerald Krueger to its scientific advisory board. Krueger is a professor of dermatology and Edna Benning Presidential Endowed Chair at the University of Utah. He received his medical degree from Loma Linda University and completed his residency in dermatology at the University of Colorado. Krueger is also the recipient of the Taub International Award for Psoriasis Research and a National Psoriasis Foundation Lifetime Achievement Award. DermTech noted that Krueger will help guide the company's efforts to develop non-invasive gene expression tests for inflammatory skin conditions.

Sep 08, 2017

Jamie Platt

Jamie Platt has joined Inivata as chief operations officer. She will be based at Inivata's Research Triangle Park, North Carolina facility. Platt joins Inivata from Quest Diagnostics, where she helped lead that company's early advanced sequencing strategy and product portfolio. She holds a PhD in molecular and cellular biology from Oregon State University and completed her postdoc in population genetics at the University of California, Berkeley.

Sep 06, 2017

Michael Brawer

MDxHealth has appointed Michael Brawer as chief medical officer. Brawer is a urologist and former professor of urology and pathology. He most recently served as vice president of medical affairs for urology at Myriad Genetics, where he led all clinical aspects of development, education, and commercialization of the firm's prognostic prostate cancer assay. Previously, Brawer held senior leadership positions at GTx, Tokai Pharmaceuticals, and Threshold Pharmaceuticals. HE was also a practicing urologist and the director of the Northwest Prostate Institute for almost a decade, and held teaching positions in pathology and urology at the University of Washington and University of Arizona.

Sep 06, 2017

Sandra Cole

BioReference Laboratories has appointed Sandra Cole vice president and chief compliance officer. Previously, she served as the company’s compliance and privacy officer. In her new role, Cole will oversee a department responsible for restructuring the company’s compliance and privacy programs. In addition, she will oversee core compliance processes, including risk assessments, metrics, analytics, and corporate policy.

Sep 05, 2017

Christopher Rieder

Christopher Rieder has joined Aurora Diagnostics as its chief information officer. Rieder was most recently CIO of Brookdale University Hospital and Medical Center and has more than 20 years of experience in information technology and a background in operations, management, and organizational leadership.

Sep 05, 2017

Michael Vicari

OncoCyte has appointed Michael Vicari to a newly created position of vice president of sales, in which he will report directly to president and CEO William Annett. In his new role, Vicari will be responsible for the development and successful implementation of domestic and international sales strategies for OncoCyte, with an initial focus on the expected fourth quarter US launch of the firm's liquid biopsy lung cancer test DetermaVu.

Vicari comes with 35 years of successful sales and marketing leadership within the healthcare industry, including the launch of several important diagnostic products, OncoCyte said. He previously worked with Eurofins Scientific as VP of sales & marketing for the company's clinical diagnostics business. Prior to Eurofins, he was VP of sales for Sequenom, for Monogram Biosciences, and served in senior commercial leadership roles at Genentech, Corixa Oncology, and MedImmune.

Aug 31, 2017

Stefan Linn

Oxford Immunotec appointed Stefan Linn its chief operating officer. He was most recently senior vice president, strategy and commercial operations for IMS Health Holdings, where he was responsible for advancing that firm's global growth agenda. Prior to that, he was at TPG Capital , where he helped its healthcare and consumer portfolio firms drive operating improvements.